A metagenome-wide association study of gut microbiota in type 2 diabetes is a research paper published in Nature (2012). On theSindex it has a DataRank of 1.3. It has been cited 6,886 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.3
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →European Commission FP7
Grant: FP7_201052
Wellcome Trust
Grant: unidentified
unidentified
European Commission
Grant: 201052
Metagenomics of the Human Intestinal Tract
FWCI
86.18
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 1 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 2 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 2 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 3 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 3 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 4 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 4 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 5 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 5 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 6 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 6 of Type 2 diabetes induced microbiome dysbiosis is associated with therapy resistance in pancreatic adenocarcinoma
Additional file 1 of Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial
Additional file 1 of Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial
Additional file 1 of The effect of probiotics supplementation on blood pressure: a systemic review and meta-analysis
Additional file 1 of The effect of probiotics supplementation on blood pressure: a systemic review and meta-analysis
Additional file 10 of Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection
Additional file 10 of Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection
Additional file 12 of Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection
Additional file 12 of Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection